Jie Lu

Jie Lu

Auto-generated profile, based on publicly available information

Jie Lu

Jinan University

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2021 in Frontiers in Pharmacology
Verified
Journal Article
Open access
MRMohammad Nasiruddin Rana
Mohammad Nasiruddin Rana
JLJie Lu
Jie Lu
EXEnfu Xue
Enfu Xue
JRJingjing Ruan
Jingjing Ruan
宇刘宇婷 刘
宇婷 刘
HTHuifang Tang
Huifang Tang
Ulcerative colitis (UC) is a form of inflammatory bowel disease, which manifests as irritation or swelling and sores in the large intestine in a relapsing and remitting manner. In a dextran sulfate sodium sulfate (DSS)-induced UC model in female mice, we found that the levels of cyclic guanosine monophosphate (cGMP) are reduced, while the expression of phosphodiesterase 9A (PDE9A) is highest among all phosphodiesterase (PDEs). Since PDE9 has the highest affinity toward cGMP, we evaluated the selective PDE9 inhibitor PF-04447943 (PF) as a potential candidate for UC treatment. PF has been extensively studies in cognitive function and in sickle cell disease, but not in models for inflammatory bowel disease (IBD). Therefore, we used female C57BL/6 mice treated with 3% DSS alone or co-treated with PF or sulfasalazine (SASP) to study the body weight, colon length, histopathology, and measure superoxide dismutase (SOD), malondialdehyde (MDA), and cGMP level, as well as cytokines such as tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), interleukin-17 (IL-17), interleukin-12/23 (IL-12/23), interleukin-10 (IL-10), and pathways including nuclear factor kappa B (NF-κB), signal transducer and activator of transcription 3 (STAT3), and inflammasome activation. In addition, the number of dendritic cells (DC) and regulatory T cells (Treg cell) was assessed in the spleen, lymph node, and colon using flow cytometry. DSS reduced the number of goblet cells, decreased colon lengths and body weights, all of them were attenuated by PF treatment. It also suppressed the elevated level of inflammatory cytokines and increased level the anti-inflammatory cytokine, IL-10. PF treatment also reduced the DSS-induced inflammation by suppressing oxidative stress, NF-κB, STAT3, and inflammasome activation, by upregulating nuclear factor erythroid 2-related factor 2 (Nrf-2) and its downstream proteins via extracellular signal-regulated kinase (ERK) phosphorylation. Importantly, PF reversed imbalance in Treg/T helper 17 cells (Th17) cells ratio, possibly by regulating dendritic cells and Treg developmental process. In summary, this study shows the protective effect of a PDE9A inhibitor in ulcerative colitis by suppressing oxidative stress and inflammation as well as reversing the Treg/Th17 cells imbalance.

14 January 2016 in Acta Oto-Laryngologica
Verified
Journal Article
Closed access
PDF file
SHShujing Han
Shujing Han
XYXiaojian Yang
Xiaojian Yang
Yi ZhouYi Zhou
Yi Zhou
JHJinsheng Hao
Jinsheng Hao
ASAdong Shen
Adong Shen
XNXin Ni
Xin Ni
Objective To determine the incidence of congenital hearing loss (HL) in newborns by the rate of deafness-related genetic mutations. Design Clinical study of consecutive newborns in Beijing using allele-specific polymerase chain reaction-based universal array. Study sample This study tested 37 573 newborns within 3 days after birth, including nine sites in four genes: GJB2 (35 del G, 176 del 16, 235 del C, 299 del AT), SLC26A4 (IVS7-2 A > G, 2168 A > G), MTRNR1 (1555 A > G, 1494 C > T), and GJB3 (538 C > T). The birth condition of infants was also recorded. Results Of 37 573 newborns, 1810 carried pathogenic mutations, or 4.817%. The carrier rates of GJB2 (35 del G, 176 del 16, 235 del C, 299 del AT), GJB3 (538 C > T), SLC26A4 (IVS7-2 A > G, 2168 A > G), and MTRNR1 (1555 A > G, 1494 C > T) mutations were 0.005%, 0.104%, 1.924%, 0.551%, 0.295%, 0.253%, 1.387%, 0.024%, and 0.274%, respectively. Logistic regression analysis indicated no statistically significant relationship between mutations and infant sex, premature delivery, twin status, or birth weight. Conclusions The 235delC GJB2 mutation was the most frequent deafness-related mutation in the Chinese population. Genetic screening for the deafness gene will help detect more cases of newborn congenital HL than current screening practices.

1 January 2019 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
HZHuiwen Zheng
Huiwen Zheng
DLDongxin Liu
Dongxin Liu
JLJie Lu
Jie Lu
YSYuanyuan Song
Yuanyuan Song
SWShengfen Wang
Shengfen Wang
XNXin Ni
Xin Ni
Treatment efficacy of Mycobacterium abscessus infections depends on bacterial genotype. Here the relationship between genotype, as determined using sequence analysis, and antibiotic resistance phenotype was analyzed. The results demonstrate that Mycobacterium abscessus genotype characteristics, including erm(41) sequevar, and mutations of rrl and rrs, are predictive of clarithromycin and amikacin resistance.


20 October 2023 in Annals of Oncology
Verified
Journal Article
Closed access
JZJUN ZHAO
JUN ZHAO
YZY. Zhang
Y. Zhang
WHWenqing Hu
Wenqing Hu
YDY. Du
Y. Du
XZX. Zhang
X. Zhang
JLJ. Lu
J. Lu

1 June 2023 in Human Reproduction
Verified
Journal Article
Open access
PDF file
LQL Qin
L Qin
CCChen Chen
Chen Chen
JWJ Wu
J Wu
LPL C Poon
L C Poon
CWC Wang
C Wang
YWYanfang Wang
Yanfang Wang
The perturbations in serum levels of soluble forms of programmed cell death-1 (sPD-1) and its ligand (sPD-L1) in missed miscarriage (MM) are unknown. Dysfunction in PD-L1 signal has been demonstrated in MM as evidenced by a lower circulating sPD-L1 level and declined expressions of PD-L1 in placenta. Programmed cell death-1 (PD-1) and its ligand (PD-L1) comprise important immune inhibitory checkpoint signaling to maintain pregnancy. During pregnancy, PD-L1 is highly expressed in the trophoblasts of the placenta. The reduced placental PD-L1 expression is associated with the risk of miscarriage. Therefore, disturbance of PD-1/PD-L1 axis in the fetomaternal interface is susceptible to be an important pathogenesis for pregnancy loss. Interestingly, the soluble form of these immune checkpoint molecules is detectable and associated with immunosuppression, it raises the diagnostic potential to monitor their level to monitor pregnancy health. In the discovery cohort, we enrolled 108 patients with MM and 115 body mass index (BMI)-matched, healthy women with a full-term pregnancy at 6 to 13 weeks of gestation. Another cohort of 25 MM patients and 25 subjects with induced abortion was recruited for validation. Blood samples were collected at the first prenatal visit for HP women or on the day of dilatation and curettage surgery (D&C) for subjects with MM or IA to measure serum sPD-1 and sPD-L1 levels. Placenta samples were harvested during the D&C within cohort 2 to examine related gene and protein expression. Our results showed that circulating sPD-L1 levels were reduced by 50% in patients with MM (55.71 ± 1.54 pg/mL) compared to HP controls (107.27 ± 5.48 pg/mL, P<0.001) and remained significant after adjusting for maternal age and gestational age, whereas no significant differences in sPD-1 were observed between the two groups. Applying serum sPD-L1 levels achieved an area under the receiver operating characteristics curve (AUROC) of 0.83 (95% CI: 0.77 to 0.88, P<0.001) with the optimal cut-off value of 81.52 pg/ml to detect MM. Our data in the validation cohort further demonstrated that sPD-L1 was lower in MM patients relative to IA subjects. Likewise, placental PD-L1-related gene expressions were downregulated at both mRNA and protein levels in miscarriage samples relative to samples in IA groups and were positively associated with sPD-L1 levels in maternal circulation This study was conducted in East Asian women, further studies are required for the evaluation of the serum PD-1 and sPD-L1 levels in different ethnic groups. Secondly, due to the cross-sectional nature of the study design, whether the sPD-L1 levels could utilize as a predictive biomarker is questioned. The maternal serum sPD-L1 level has the potential to be a diagnostic aid for pregnancy maintenance. Moreover, insufficient PD-L1 expression in the feto-maternal interface may act as one of the potential pathogenic events to trigger early pregnancy loss. not applicable